Suppr超能文献

溶解状态与标准剂量和低剂量冠状动脉内链激酶成功再灌注的关系。

Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.

作者信息

Rothbard R L, Fitzpatrick P G, Francis C W, Caton D M, Hood W B, Marder V J

出版信息

Circulation. 1985 Mar;71(3):562-70. doi: 10.1161/01.cir.71.3.562.

Abstract

The influence of a systemic lytic state on reperfusion obtained after intracoronary streptokinase (SK) therapy has been evaluated in 15 patients with acute myocardial infarction and complete coronary occlusion. Coronary angiographic studies and measurements of blood fibrinolytic parameters were repeated at 15 min intervals during the infusion of a standard dose of SK and were compared with the results with approximately one-tenth the standard dose. Successful reperfusion was obtained in only 20% (2/10) of patients receiving the low dose, compared with a 75% to 80% success rate in patients receiving the standard dose as initial treatment (4/5) or as follow-up treatment of patients in whom low-dose therapy failed (6/8). There was a striking association between reperfusion and development of the lytic state in that all 12 treatments resulting in reperfusion also caused a lytic state and all seven treatments that failed to produce a lytic state also failed to induce reperfusion (p less than .001). Among the successfully treated patients, the dose of SK that induced a lytic state was relatively constant. However, coronary arterial thrombi differed in susceptibility to treatment. Sensitive thrombi (5/12) dissolved before the lytic state occurred and at a lower SK dose than that needed to cause a lytic state; more resistant thrombi (7/12) required a longer time and a significantly larger SK dose to dissolve. These results indicate that intrinsic properties of the thrombus influence the rate and outcome of treatment and that a minimal dose of SK (about 200,000 U) is required to ensure lasting reperfusion in susceptible patients.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在15例急性心肌梗死且冠状动脉完全闭塞的患者中,评估了全身纤溶状态对冠状动脉内注射链激酶(SK)治疗后再灌注的影响。在输注标准剂量SK期间,每隔15分钟重复进行冠状动脉造影研究和血液纤溶参数测量,并与约十分之一标准剂量的结果进行比较。接受低剂量治疗的患者中只有20%(2/10)成功实现再灌注,而接受标准剂量作为初始治疗的患者(4/5)或作为低剂量治疗失败患者的后续治疗的患者(6/8)的成功率为75%至80%。再灌注与纤溶状态的发展之间存在显著关联,即所有导致再灌注的12次治疗均引起了纤溶状态,而所有7次未能产生纤溶状态的治疗也未能诱导再灌注(p<0.001)。在成功治疗的患者中,诱导纤溶状态的SK剂量相对恒定。然而,冠状动脉血栓对治疗的敏感性不同。敏感血栓(5/12)在纤溶状态出现之前溶解,且所需的SK剂量低于引起纤溶状态所需的剂量;更具抗性的血栓(7/12)需要更长时间和显著更大剂量的SK才能溶解。这些结果表明,血栓的内在特性影响治疗的速度和结果,并且需要最小剂量的SK(约200,000 U)以确保易感患者实现持久再灌注。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验